文献速递外周动脉疾病

单独旋转斑块旋切术与联合药物涂层球囊血管成形术治疗重度钙化股腘及腘动脉病变的血管内治疗对比

Stand-Alone Rotational Atherectomy Versus Combination With Drug-Coated Balloon Angioplasty for the Endovascular Treatment of Heavily-Calcified Femoropopliteal and Popliteal Lesions.
PubMed 文献 · J Endovasc Ther · 2023-12-26

该回顾性研究分析264例重度钙化股腘及孤立腘动脉病变,其中53例在旋切术后联合药物洗脱球囊(DEB)血管成形术。平均随访19个月,临床驱动靶病变血运重建(CD-TLR)在单独旋切与旋切后DEB之间无显著差异;ABI和Rutherford分级均改善。作者认为旋切联合DEB安全有效,但未显著提高免于TLR率,需大规模随机试验验证。

要点

  • 重度钙化股腘及腘动脉病变旋切术后联合DEB与单独旋切相比,CD-TLR无显著差异。
  • 平均随访19个月,股腘病变CD-TLR为14.7%,孤立腘动脉病变为23.9%。
  • ABI从术前0.57±0.22改善至术后0.86±0.23,随访时0.83±0.16保持稳定。

核心结论

  • 真实世界研究提示旋切联合DEB安全有效,但在本人群中未显著影响免于靶病变血运重建率。
  • 作者认为需要额外的大规模随机试验来验证这些发现。

研究设计与样本

  • 回顾性分析264例重度钙化股腘及孤立腘动脉病变,其中股腘病变218例、腘动脉病变46例。
  • 53例在旋切术后接受药物洗脱球囊(DEB)血管成形术,其中股腘病变43例、腘动脉病变10例。
  • 病变长度17.3±12.1 cm,TASC C占48.4%、TASC D占19.7%。
  • 平均随访19±11个月。

主要发现

  • 随访期间共12例患者(4.5%)死亡。
  • 临床驱动靶病变血运重建(CD-TLR)在股腘病变为32例(14.7%),在孤立腘动脉病变为11例(23.9%)。
  • CD-TLR在单独旋切与旋切后DEB之间无显著差异。
  • 平均ABI从干预前0.57±0.22改善至干预时0.86±0.23,随访时0.83±0.16保持稳定。
  • 随访期间平均Rutherford分级从3.64±1.0降至2.38±0.98。

临床怎么用

  • 作者认为旋切联合DEB安全有效,但未显著提高免于靶病变血运重建率。
  • 作者建议需要额外的大规模随机试验来验证这些发现。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite major technical advances in the endovascular treatment for peripheral artery disease (PAD), heavy calcification still represents a major obstacle to overcome both due to the high number of periprocedural complications (dissections, embolization, etc) and the limited long-term durability. A promising tool to overcome these obstacles is debulking calcified lesions with atherectomy. Since vessel preparation with atherectomy might even improve the diffusion of antiproliferative substances, we wanted to evaluate the impact of atherectomy±DCB in lower extremity PAD. OBJECTIVES: To explore the safety, efficacy, and long-term durability on treatment of rotational atherectomy in heavily-calcified complex femoropopliteal and isolated popliteal lesions. In addition, we wanted to investigate whether advanced debulking strategies where atherectomy is followed by a drug-coated angioplasty bear an additional advantage over atherectomy and standard percutaneous angioplasty alone in terms of clinical success and freedom from target lesion revascularization. RESULTS: In total, 218 femoropopliteal and 46 popliteal predominantly heavily-calcified lesions have been investigated. Of 264 cases, in a total of 53 cases, atherectomy treatment was followed by a drug-eluting balloon (DEB) angioplasty (43 in the femoropopliteal and 10 in the popliteal lesions). The lesions were characterized by a significant length (17.3±12.1 cm) and complexity (TASC C in 48.4% and TASC D in 19.7%). During a mean follow-up of 19 (±11) months, a total of 12 patients (4.5%) died. Clinically-driven target lesion revascularization (CD-TLR) was performed in 32 (14.7%) femoropopliteal and 11 isolated popliteal (23.9%) lesions and did not differ significantly between stand-alone atherectomy and atherectomy followed by a DEB. Mean ABI was improved from 0.57±0.22 immediately before intervention to 0.86±0.23 on intervention and remained stable: 0.83±0.16 at follow-up. During follow-up, a mean Rutherford category was reduced from 3.64±1.0 to 2.38±0.98. CONCLUSIONS: Our real-life study provides evidence that atherectomy in combination with DEB is safe and effective but did not have a significant impact on the freedom from target lesion revascularization in our population. Additional large-scale randomized trials are needed to verify these findings.Clinical ImpactThis study investigates the efficacy and safety of combining rotational atherectomy with drug-coated balloon (DCB) angioplasty for treating heavily calcified femoropopliteal and isolated popliteal lesions in peripheral artery disease (PAD). The retrospective analysis of 264 patients highlights the potential of this combination in improving procedural success and reducing periinterventional complications. While demonstrating an excellent procedural and clinical success rate over an average 19-month follow-up, the study finds no significant long-term benefit in freedom from target lesion revascularization (TLR) compared to atherectomy alone. These findings suggest the need for further research to optimize treatment strategies for complex PAD cases, particularly in evaluating the long-term clinical benefits of such combined interventions.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Kronlage M, Bertele M, Linden F, et al. Stand-Alone Rotational Atherectomy Versus Combination With Drug-Coated Balloon Angioplasty for the Endovascular Treatment of Heavily-Calcified Femoropopliteal and Popliteal Lesions. J Endovasc Ther. 2023. PMID: 38146867. doi:10.1177/15266028231219663

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。